Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Blood Cancer Journal|July 2, 2025
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignanciesSigrun Einarsdottir, Stephanie Lobaugh, Danny Luan, et al.
Blood Cancer Journal|February 2, 2020
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomasManit Munshi, Xia Liu, Jiaji G Chen, et al.
British Journal of Haematology|December 15, 2015
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström MacroglobulinaemiaLian Xu, Zachary R Hunter, Nicholas Tsakmaklis, et al.
Blood Advances|June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomasGustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
British Journal of Haematology|July 1, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experienceGiulio Cassanello, Efrat Luttwak, Samantha Brown, et al.
Transplantation and Cellular Therapy|May 24, 2026
Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignanciesMarina Gomez-Llobell, Silvia Escribano Serrat, Maria Bromberg, et al.
The Journal of Clinical Investigation|May 17, 2013
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activityArnab Ghosh, Yildirim Dogan, Maxim Moroz, et al.
Blood Cancer Journal|April 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphomaAlejandro Luna, Sean M Devlin, Kai Rejeski, et al.
Blood Advances|August 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphomaXavier Deschênes-Simard, Maria Bromberg, Sean M Devlin, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Pageof 12